Jubilant Pharmova's Stock Soars 3.85%, Listed as 'Reliable Performer' by MarketsMOJO
Jubilant Pharmova, a leading pharmaceutical company in the largecap industry, has been making headlines with its recent stock performance. On November 6th, 2024, the company's stock gained 3.85%, closing at Rs 1278.75. This positive movement has been attributed to the company's strong financials and consistent growth in the pharmaceutical sector.
MarketsMOJO, a renowned stock analysis platform, has given a 'Strong Buy' call for Jubilant Pharmova's stock. The company has also been listed as a part of the 'Reliable Performers' on MarketsMOJO since October 31st, 2024. This further solidifies the company's position as a top performer in the market.
Jubilant Pharmova's stock is currently trading close to its 52-week high, with only a 1.39% difference. This shows the company's resilience and stability in the market, even during uncertain times. In fact, the stock has outperformed the sector by 2.68% today, indicating a strong demand for the company's products and services.
The stock has also shown a trend reversal, gaining after two consecutive days of fall. This is a positive sign for investors, as it indicates a potential upward trend in the near future. On November 6th, the stock touched an intraday high of Rs 1280, a 3.85% increase from the previous day's close.
Jubilant Pharmova's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong and consistent performance by the company, making it an attractive investment option for investors.
In comparison to the overall market performance, Jubilant Pharmova's stock has outperformed the Sensex by 2.72% in just one day. In the past month, the stock has shown a remarkable 14.78% increase, while the Sensex has seen a decline of -1.60%. This further highlights the company's strong financials and growth potential.
Overall, Jubilant Pharmova's recent stock performance has been impressive, showcasing the company's strong position in the pharmaceutical industry. With a 'Strong Buy' call from MarketsMOJO and consistent growth, the company is definitely one to watch out for in the largecap market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
